SPONSORED CONTENT

Biotechnology e-Symposium in Delhi: Impacts on human health in 21st Century

January 07, 2021 23:30 IST
Tennis player James Blake
Biotechnology e-Symposium on the topic "Biotechnology- Impact on Human Health in 21st century"

New Delhi [India], January 7 (ANI/Digpu): Biotechnology plays a definitive role in meeting the unmet medical needs and the advancement of the healthcare sector by bringing innovative new technologies and therapies to market.

To showcase this potential of Biotechnology, StemMax Research and Therapeutics Pvt Ltd conducted an e-symposium on the topic "Biotechnology- Impact on Human Health in 21st century" on 2nd January, 2021. This event witnessed the launch of "Otlu-Academy", a unit of StemMax which is established with the goal of training the students of Life Sciences and Allied Health Sciences students in the key areas of Stem Cell, Molecular Medicine, Immunology, Cell Culture, Biotechnology and Embryology, thereby, enhancing their chances of successful employment and a better future in the healthcare industry.

The event was opened by Dr Nidhi Khurana, Chief Scientific Officer, StemMax Research and had three sessions which focused on the 'Role of Biotechnology in advancing diagnostics and therapeutics', 'Impact of Advancing Translational Medicine on Innovation', and 'Career perspectives in Biotechnology and Human Health. To address these walks of advanced Biotechnology, speakers from a vast horizon of expertise were invited.

"Dr Shilpa Sharma, pediatric surgeon from AIIMS highlighted on Stem Cell application to treat Liver Cirrhosis which exploits the innate capability of the body to regenerate liver. Dr Atul Sardana shed light on the use of adipose stem cells technology for the point of care treatment. Prof Dr Arvind Chhabra, Amity University put forth various career avenues of Biotechnology in the light of advancing healthcare technology."

Video Link for Embedding:

The other speakers Dr Suman Chakraborty from IIT Kharagpur; Dr. Kanchan Mishra, Surya Raktadan Kendra and research center; Dr Nidhi Jha, Care and Cure Clinic; Dr Saurabh Jha, Sharda University, and Dr Rashmi Mishra, NIET enlightened the young minds by sharing their knowledge and experience with respect to the potential of biotechnology and its impact on Human Health.

From advancing diagnostics and therapeutics to advancing translational medicine, biotechnology is continuing to touch our lives in a way which leads to meeting the unmet medical needs through innovation. The seed of innovation lies within a human mind and if nurtured in the right manner will yield a fruitful result. Ironically, a large percentage of young minds do not get this opportunity where their talent is nurtured or they gain practical skills.

The bitter truth is that, "Theory" in case of applied sciences subjects can only do so much and most of it relies in the practical skill training. So to witness the potential of Biotechnology happening in real time, it is important that the young minds are given the right kind of hands on experience and practical skills in the emerging areas of translational health so that they are firstly updated with the latest healthcare technology trends, understand the direction where the advancement is needed and finally contribute to this growing sector.

"Our idea behind Otlu Academy is exactly to help the students gain practical skills training and provide certificate/ degree programs in the emerging and promising field of Stem Cells, Gene therapy, Regenerative Medicine, Immunotherapy, Molecular Medicine and Basic Molecular biology skills. Our vision for Otlu Academy is to establish it as a dedicated Institute with a profound global network for excelling in advancing healthcare technologies where innovation is fostered, and students are prepared for employability in healthcare industry", said Prabhu Mishra, CEO, StemMax Research and therapeutics Pvt Ltd.

StemMax Research and Therapeutics Pvt. Ltd. (WHO GMP compliance certified) is dedicated to advancing the field of Regenerative Medicine & Molecular Medicine by offering the highest quality technology, cellular therapy and training. We are an international Med Tech company focused in developing safer and more effective therapies that can address crucial unmet medical needs and meliorate the lives of patients with latest advances in Stem Cell Therapies & Regenerative Medicine.

We are committed to promote education and research by collaboration with Universities, Industries, Pharmaceutical companies, Individual Doctors, Researchers and Hospitals. StemMax organizes training courses for medical doctors like 'Fellowship in Stem Cell and Regenerative Medicine', 'Diploma in Cosmetic Gynaecology', and other short-term courses.

This story is provided by Digpu. ANI will not be responsible in any way for the content of this article. (ANI/Digpu)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Biotechnology e-Symposium in Delhi: Impacts on human health in 21st Century

New Delhi [India], January 7 (ANI/Digpu): Biotechnology plays a definitive role in meeting the unmet medical needs and the advancement of the healthcare sector by bringing innovative new technologies and therapies to market.

To showcase this potential of Biotechnology, StemMax Research and Therapeutics Pvt Ltd conducted an e-symposium on the topic "Biotechnology- Impact on Human Health in 21st century" on 2nd January, 2021. This event witnessed the launch of "Otlu-Academy", a unit of StemMax which is established with the goal of training the students of Life Sciences and Allied Health Sciences students in the key areas of Stem Cell, Molecular Medicine, Immunology, Cell Culture, Biotechnology and Embryology, thereby, enhancing their chances of successful employment and a better future in the healthcare industry.

The event was opened by Dr Nidhi Khurana, Chief Scientific Officer, StemMax Research and had three sessions which focused on the 'Role of Biotechnology in advancing diagnostics and therapeutics', 'Impact of Advancing Translational Medicine on Innovation', and 'Career perspectives in Biotechnology and Human Health. To address these walks of advanced Biotechnology, speakers from a vast horizon of expertise were invited.

"Dr Shilpa Sharma, pediatric surgeon from AIIMS highlighted on Stem Cell application to treat Liver Cirrhosis which exploits the innate capability of the body to regenerate liver. Dr Atul Sardana shed light on the use of adipose stem cells technology for the point of care treatment. Prof Dr Arvind Chhabra, Amity University put forth various career avenues of Biotechnology in the light of advancing healthcare technology."

Video Link for Embedding:

The other speakers Dr Suman Chakraborty from IIT Kharagpur; Dr. Kanchan Mishra, Surya Raktadan Kendra and research center; Dr Nidhi Jha, Care and Cure Clinic; Dr Saurabh Jha, Sharda University, and Dr Rashmi Mishra, NIET enlightened the young minds by sharing their knowledge and experience with respect to the potential of biotechnology and its impact on Human Health.

From advancing diagnostics and therapeutics to advancing translational medicine, biotechnology is continuing to touch our lives in a way which leads to meeting the unmet medical needs through innovation. The seed of innovation lies within a human mind and if nurtured in the right manner will yield a fruitful result. Ironically, a large percentage of young minds do not get this opportunity where their talent is nurtured or they gain practical skills.

The bitter truth is that, "Theory" in case of applied sciences subjects can only do so much and most of it relies in the practical skill training. So to witness the potential of Biotechnology happening in real time, it is important that the young minds are given the right kind of hands on experience and practical skills in the emerging areas of translational health so that they are firstly updated with the latest healthcare technology trends, understand the direction where the advancement is needed and finally contribute to this growing sector.

"Our idea behind Otlu Academy is exactly to help the students gain practical skills training and provide certificate/ degree programs in the emerging and promising field of Stem Cells, Gene therapy, Regenerative Medicine, Immunotherapy, Molecular Medicine and Basic Molecular biology skills. Our vision for Otlu Academy is to establish it as a dedicated Institute with a profound global network for excelling in advancing healthcare technologies where innovation is fostered, and students are prepared for employability in healthcare industry", said Prabhu Mishra, CEO, StemMax Research and therapeutics Pvt Ltd.

StemMax Research and Therapeutics Pvt. Ltd. (WHO GMP compliance certified) is dedicated to advancing the field of Regenerative Medicine & Molecular Medicine by offering the highest quality technology, cellular therapy and training. We are an international Med Tech company focused in developing safer and more effective therapies that can address crucial unmet medical needs and meliorate the lives of patients with latest advances in Stem Cell Therapies & Regenerative Medicine.

We are committed to promote education and research by collaboration with Universities, Industries, Pharmaceutical companies, Individual Doctors, Researchers and Hospitals. StemMax organizes training courses for medical doctors like 'Fellowship in Stem Cell and Regenerative Medicine', 'Diploma in Cosmetic Gynaecology', and other short-term courses.

This story is provided by Digpu. ANI will not be responsible in any way for the content of this article. (ANI/Digpu)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22